SE503233C2 - Sukralfat beredning och förfarande för framställning av densamma - Google Patents

Sukralfat beredning och förfarande för framställning av densamma

Info

Publication number
SE503233C2
SE503233C2 SE8701787A SE8701787A SE503233C2 SE 503233 C2 SE503233 C2 SE 503233C2 SE 8701787 A SE8701787 A SE 8701787A SE 8701787 A SE8701787 A SE 8701787A SE 503233 C2 SE503233 C2 SE 503233C2
Authority
SE
Sweden
Prior art keywords
polyethylene glycol
sucralfate
turbidity
acceleration
preparing
Prior art date
Application number
SE8701787A
Other languages
English (en)
Swedish (sv)
Other versions
SE8701787L (sv
SE8701787D0 (sv
Inventor
Yoshimitsu Iida
Minoru Machida
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of SE8701787D0 publication Critical patent/SE8701787D0/xx
Publication of SE8701787L publication Critical patent/SE8701787L/
Publication of SE503233C2 publication Critical patent/SE503233C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Cephalosporin Compounds (AREA)
SE8701787A 1986-04-30 1987-04-29 Sukralfat beredning och förfarande för framställning av densamma SE503233C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9990186 1986-04-30

Publications (3)

Publication Number Publication Date
SE8701787D0 SE8701787D0 (sv) 1987-04-29
SE8701787L SE8701787L (sv) 1987-10-31
SE503233C2 true SE503233C2 (sv) 1996-04-22

Family

ID=14259677

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701787A SE503233C2 (sv) 1986-04-30 1987-04-29 Sukralfat beredning och förfarande för framställning av densamma

Country Status (9)

Country Link
JP (1) JP2542210B2 (it)
DE (1) DE3714159C2 (it)
DK (1) DK167735B1 (it)
ES (1) ES2017805A6 (it)
FI (1) FI89457C (it)
FR (1) FR2598084B1 (it)
IT (1) IT1208416B (it)
NO (1) NO174085C (it)
SE (1) SE503233C2 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2735559B2 (ja) * 1988-03-02 1998-04-02 中外製薬株式会社 懸濁液
ATE213635T1 (de) * 1994-04-26 2002-03-15 Chugai Pharmaceutical Co Ltd Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung
EP0808629A4 (en) * 1995-02-02 1998-03-04 Chugai Pharmaceutical Co Ltd Sucralfate preparation
ES2112765B1 (es) * 1995-08-02 1999-03-01 Cantabria Ind Farmaceutica Sa Procedimiento para la obtencion de formulaciones de constraste radiologico, para exploraciones gastrointestinales de uso extemporaneo y directo.
WO2011102505A1 (ja) * 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
ES2706880T3 (es) 2010-02-22 2019-04-01 Daiichi Sankyo Co Ltd Preparación sólida de liberación sostenida para uso oral
CA2883077C (en) 2012-09-03 2017-03-07 Daiichi Sankyo Company, Limited Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3430809A1 (de) * 1984-08-22 1986-03-06 Merck Patent Gmbh, 6100 Darmstadt Sucralfat-suspension

Also Published As

Publication number Publication date
NO871759D0 (no) 1987-04-28
ES2017805A6 (es) 1991-03-01
FI89457C (fi) 1993-10-11
FR2598084A1 (fr) 1987-11-06
JPS63107933A (ja) 1988-05-12
SE8701787L (sv) 1987-10-31
NO871759L (no) 1987-11-02
FR2598084B1 (fr) 1991-04-26
DK167735B1 (da) 1993-12-13
IT8767365A0 (it) 1987-04-29
IT1208416B (it) 1989-06-12
SE8701787D0 (sv) 1987-04-29
FI871852A0 (fi) 1987-04-28
DK218587A (da) 1987-10-31
JP2542210B2 (ja) 1996-10-09
FI89457B (fi) 1993-06-30
DK218587D0 (da) 1987-04-29
FI871852L (fi) 1987-10-31
NO174085C (no) 1994-03-16
DE3714159C2 (de) 1996-09-19
NO174085B (no) 1993-12-06
DE3714159A1 (de) 1987-11-05

Similar Documents

Publication Publication Date Title
US4261970A (en) Theophylline sustained release granule
Millili et al. The strength of microcrystalline cellulose pellets: the effect of granulating with water/ethanol mixtures
EP0124027B1 (en) Rapid dissolving, uniform drug compositions and their preparation
GB2249957A (en) Controlled release composition
CN109248155B (zh) 一种罗红霉素胶囊及其制备工艺
SE503233C2 (sv) Sukralfat beredning och förfarande för framställning av densamma
CN115006358B (zh) 一种恩格列净口服片剂及其制备方法
EP1256338B1 (en) A process for the preparation of direct tabletting formulations and aids
US5683719A (en) Controlled release compositions
Chakravarty et al. Phase transformation in thiamine hydrochloride tablets: influence on tablet microstructure, physical properties, and performance
Dabbagh et al. Investigation of solid dispersion technique in improvement of physicochemical characteristics of ibuprofen powder
DE602004006507T2 (de) Amoxicillintrihydrat
US5514383A (en) Process for the preparation of tablets of derivatives of cephalosporanic acid by direct compression
US5547943A (en) Sucralfate preparation
CN115531330B (zh) 一种孟鲁司特钠咀嚼片的制备方法
SU1478993A3 (ru) Способ получени микрогранул
CN109745293B (zh) 一种含有枸橼酸莫沙必利的药物组合物
CA2024863C (en) The manufacture of pellets of xanthine derivatives
Jalil et al. Effect of viscosity increasing agent and electrolyte concentration on the release rate of theophylline from a HPMC based sustained release capsules
AU2019101654A4 (en) Vitamin mineral tablet and preparation method thereof
CN103772378B (zh) 一种美洛昔康化合物及其片剂
IE42952B1 (en) Tablet formulation
CN113274363B (zh) 一种吲达帕胺制剂
Sahu et al. Formulation and evaluation of effervescent floating tablet of levofloxacin
Okolo et al. NOVEL APPLICATIONS OF LOCALLY SOURCED MONTMORILLONITE (MMT) CLAY AS A DISINTEGRANT IN THE FORMULATION OF PHARMACEUTICAL PRODUCT.

Legal Events

Date Code Title Description
NUG Patent has lapsed